Logo image of NZM2.DE

NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:NZM2 - DK0060336014 - Common Stock

54.68 EUR
+0.14 (+0.26%)
Last: 1/8/2026, 7:00:00 PM

NZM2.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap22.67B
Revenue(TTM)5.16B
Net Income(TTM)702.70M
Shares414.56M
Float346.28M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend0.67
Dividend Yield1.58%
EPS(TTM)1.51
PE36.21
Fwd PE26.7
Earnings (Next)02-25 2026-02-25/amc
IPO1905-05-27
Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals


NZM2.DE short term performance overview.The bars show the price performance of NZM2.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 1 2 3

NZM2.DE long term performance overview.The bars show the price performance of NZM2.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of NZM2.DE is 54.68 EUR. In the past month the price increased by 2.78%.

NOVONESIS (NOVOZYMES) B / NZM2 Daily stock chart

NZM2.DE Competitors/Peers

The largest stocks on the EU markets in the "Specialty Chemicals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
AKU1.DE AKZO NOBEL N.V. 16.15 10.06B
AKZA.AS AKZO NOBEL N.V. 16.33 10.17B
SY1.DE SYMRISE AG 19.3 9.79B
SYENS.BR SYENSQO SA 21.85 7.38B
1EVK.MI EVONIK INDUSTRIES AG 7.95 6.18B
EVK.DE EVONIK INDUSTRIES AG 9.76 6.19B
UMI.BR UMICORE 17.27 4.81B
NVJP.DE UMICORE 17.01 4.74B
AKE.PA ARKEMA 10.36 4.06B
WCH.DE WACKER CHEMIE AG 163.37 3.66B
RBT.PA ROBERTET SA 18.76 1.91B
ACT.DE ALZCHEM GROUP AG 27.51 1.71B

About NZM2.DE

Company Profile

NZM2 logo image Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..

Company Info

NOVONESIS (NOVOZYMES) B

Krogshoejvej 36

Bagsvaerd DK

Employees: 10582

NZM2 Company Website

NZM2 Investor Relations

NOVONESIS (NOVOZYMES) B / NZM2.DE FAQ

What does NOVONESIS (NOVOZYMES) B do?

Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..


What is the current price of NZM2 stock?

The current stock price of NZM2.DE is 54.68 EUR. The price increased by 0.26% in the last trading session.


Does NZM2 stock pay dividends?

NOVONESIS (NOVOZYMES) B (NZM2.DE) has a dividend yield of 1.58%. The yearly dividend amount is currently 0.67.


How is the ChartMill rating for NOVONESIS (NOVOZYMES) B?

NZM2.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Is NOVONESIS (NOVOZYMES) B (NZM2.DE) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NZM2.DE.


Can you provide the upcoming earnings date for NOVONESIS (NOVOZYMES) B?

NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2026-02-25, after the market close.


NZM2.DE Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to NZM2.DE.


Chartmill TA Rating
Chartmill Setup Rating

NZM2.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to NZM2.DE. NZM2.DE has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NZM2.DE Financial Highlights

Over the last trailing twelve months NZM2.DE reported a non-GAAP Earnings per Share(EPS) of 1.51. The EPS decreased by -54.35% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.61%
ROA 4.31%
ROE 6.54%
Debt/Equity 0.26
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-54.35%
Revenue 1Y (TTM)59.91%

NZM2.DE Forecast & Estimates

23 analysts have analysed NZM2.DE and the average price target is 64.71 EUR. This implies a price increase of 18.34% is expected in the next year compared to the current price of 54.68.

For the next year, analysts expect an EPS growth of 44.83% and a revenue growth 6.01% for NZM2.DE


Analysts
Analysts74.78
Price Target64.71 (18.34%)
EPS Next Y44.83%
Revenue Next Year6.01%

NZM2.DE Ownership

Ownership
Inst Owners38.75%
Ins Owners0.01%
Short Float %N/A
Short RatioN/A